Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Sci Rep ; 10(1): 8178, 2020 05 18.
Article in English | MEDLINE | ID: mdl-32424168

ABSTRACT

Neonatal morbidities are associated with long term neurological deficits in life and have also been associated with dysbiosis. We tested whether optimizing the neonate's microbiome through maternal probiotic supplementation can improve offspring's neurodevelopmental outcomes. Maternal LB supplementation, carried out by giving Lactobacillus acidophilus and Bifidobacterium infantis (LB) to pregnant C57/BL6J mice daily from E16 to weaning, significantly suppressed postnatal peripheral proinflammatory insult-induced systemic inflammation and normalized compromised blood-brain barrier permeability and tight junction protein expression in the offspring at pre-weaned age. Maternal LB exposure also regulated markers associated with leukocyte transendothelial migration, extracellular matrix injury and neuroinflammation. The suppressed neuroinflammation by maternal LB supplementation was associated with reduced astrocyte/microglia activation and downregulation of the transcriptional regulators CEBPD and IκBα. Furthermore, maternal LB supplementation promoted neuronal and oligodendrocyte progenitor cell development. Our study demonstrates the efficacy of maternal LB supplementation in modulating systemic and central nervous system inflammation as well as promoting neural/oligodendrocyte progenitor development in the offspring. This evidence suggests that maternal probiotic supplementation may be a safe and effective strategy to improve neurological outcomes in the offspring.


Subject(s)
Brain/growth & development , Infant, Newborn, Diseases/prevention & control , Probiotics/administration & dosage , Protective Agents/administration & dosage , Animals , Animals, Newborn , Bifidobacterium longum subspecies infantis/physiology , Brain/immunology , CCAAT-Enhancer-Binding Protein-delta/genetics , CCAAT-Enhancer-Binding Protein-delta/immunology , Female , Humans , Infant, Newborn , Infant, Newborn, Diseases/genetics , Infant, Newborn, Diseases/immunology , Lactobacillus acidophilus/physiology , Male , Maternal Inheritance/drug effects , Mice , NF-KappaB Inhibitor alpha/genetics , NF-KappaB Inhibitor alpha/immunology , Pregnancy
2.
Behav Brain Res ; 348: 263-266, 2018 08 01.
Article in English | MEDLINE | ID: mdl-29698694

ABSTRACT

Our previous studies showed that paternal nicotine exposure can lead to hyperactivity in the offspring. Nevertheless, the cross-generational effects of maternal and biparental nicotine exposure remain unclear. In this study, female and male mice were exposed respectively by nicotine before pregnancy. The maternal pre-pregnancy nicotine exposure led to depression-like behaviors in the F1 offspring. However, after biparental pre-pregnancy nicotine exposure, seventy percentage of the offspring exhibited a depressive phenotype while 20% were hyperactive, and the remaining exhibited no obvious abnormal behavior. The cross-generational effects appeared to be mediated via disruption of the balance between GSK3 and p-GKS3 by nicotine. These results suggested that pre-pregnancy nicotine exposure can induce alterations in the behavior of the offspring, and the cross-generational effects of maternal nicotine exposure were particularly serious.


Subject(s)
Maternal Behavior/drug effects , Maternal Inheritance/drug effects , Nicotine/adverse effects , Animals , Behavior, Animal/drug effects , Depression/etiology , Depressive Disorder/physiopathology , Female , Glycogen Synthase Kinase 3/drug effects , Glycogen Synthase Kinase 3/metabolism , Male , Mice , Mice, Inbred C57BL , Motor Activity/drug effects , Nicotine/metabolism , Nicotine/pharmacology , Pregnancy , Prenatal Exposure Delayed Effects
SELECTION OF CITATIONS
SEARCH DETAIL
...